scholarly journals CRT-600.09 CardioHELP Support for High-Risk Percutaneous Coronary Intervention: A Single Center Case Series

2018 ◽  
Vol 11 (4) ◽  
pp. S44-S45 ◽  
Author(s):  
Derek Antoku ◽  
Wesley Ghasem ◽  
Anilkumar Mehra ◽  
Ray V. Matthews ◽  
Leonardo C. Clavijo ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Case Series ◽  
Coronary Intervention ◽  
Single Center ◽  
Percutaneous Coronary

scholarly journals Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience

2021 ◽  
Vol 40 (11) ◽  
pp. 853-861
Author(s):  
Mariana Brandão ◽  
Daniel Caeiro ◽  
Gustavo Pires-Morais ◽  
João Gonçalves Almeida ◽  
Pedro Gonçalves Teixeira ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Cardiogenic Shock ◽  
Coronary Intervention ◽  
Single Center ◽  
Single Center Experience ◽  
Percutaneous Coronary

scholarly journals Management of anti-thrombotic therapy in patients with recent percutaneous coronary intervention and acute dengue infection: A case series

2019 ◽  
Vol 28 (4) ◽  
pp. 284-287
Author(s):  
Wishnu Aditya ◽  
Jonathan Yap ◽  
Piotr Chlebicki ◽  
Charles Wah Hak Chan ◽  
Jack Wei Chieh Tan
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Dengue Infection ◽  
Case Series ◽  
Coronary Intervention ◽  
Careful Consideration ◽  
Risk Of Bleeding ◽  
Anti Platelet Therapy ◽  
Percutaneous Coronary ◽  
The Ideal

There is currently little data regarding the ideal management for a patient who has undergone recent percutaneous coronary intervention (PCI) and subsequently develops dengue fever. Patients with recent PCI are at high risk of stent thrombosis with cessation of dual anti-platelet therapy. On the other hand, patients with dengue viral infection are at high risk of bleeding. Managing patients with recent PCI and dengue involves the delicate balancing of the risk of thrombosis and bleeding. Careful consideration of the timing of coronary intervention and the severity of the dengue infection is required. We describe the management of the anti-thrombotic therapy in three different patients with dengue infection and recent PCI and discuss our approach to managing such patients.

scholarly journals Case series of high-risk percutaneous coronary intervention with rotational atherectomy under short-term mechanical circulatory support with TandemHeart in the setting of acute myocardial infarction

2020 ◽  
Vol 4 (4) ◽  
pp. 1-6
Author(s):  
Leonie Großekettler ◽  
Bastian Schmack ◽  
Hugo A Katus ◽  
Raffi Bekeredjian ◽  
Philip Raake
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Mechanical Circulatory Support ◽  
Case Series ◽  
Coronary Intervention ◽  
Circulatory Support ◽  
Assist Device ◽  
Ventricular Assist ◽  
Percutaneous Coronary

Abstract Background  TandemHeart is a percutaneous Ventricular Assist Device, most commonly used to provide mechanical circulatory support during high-risk percutaneous coronary intervention and postcardiotomy cardiac failure. However, TandemHeart has not been applied in patients with severe heart failure due to myocardial infarction during high-risk percutaneous coronary intervention with the need for rotational artherectomy (RA) before, so we present a first-in-man case series. Case summary  Three patients with severe HF[Please spell out HF, LA and MI (if necessary).] due to acute myocardial infarction revealed severely calcified lesions of the unprotected left main artery. We successfully used the TandemHeart as percutaneous Ventricular Assist Device during high-risk percutaneous coronary intervention with RA. Discussion  We here report our experience and show that RA under TandemHeart mechanical circulatory support is feasible and safe in case of acute MI.

scholarly journals Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience

2021 ◽  
Author(s):  
Mariana Brandão ◽  
Daniel Caeiro ◽  
Gustavo Pires-Morais ◽  
João Gonçalves Almeida ◽  
Pedro Gonçalves Teixeira ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Cardiogenic Shock ◽  
Coronary Intervention ◽  
Single Center ◽  
Single Center Experience ◽  
Percutaneous Coronary

scholarly journals High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation

2017 ◽  
Vol 1 ◽  
pp. 67-71
Author(s):  
Adam Sukiennik ◽  
Michał Kasprzak ◽  
Wiesław Mazurek ◽  
Piotr Niezgoda ◽  
Łukasz Bednarczyk ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Case Series ◽  
Coronary Intervention ◽  
Hemodynamic Support ◽  
Percutaneous Coronary

Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series

Perfusion ◽  
2021 ◽  
pp. 026765912110490
Author(s):  
Rafiq Ahmed Bhat ◽  
Syed Manzoor Ali ◽  
Akanksha Rathi ◽  
Javaid Akhter Bhat ◽  
Raja Saqib Iqbal ◽  
...  
Keyword(s):  
Heart Failure ◽  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Cardiogenic Shock ◽  
Case Series ◽  
Coronary Intervention ◽  
Left Ventricular ◽  
Hemodynamic Support ◽  
Percutaneous Coronary ◽  
Case Number

Background: Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention). Aim: The aim of the study was to find out whether percutaneous hemodynamic support device Impella 2.5 improves prognosis of high-risk PCI patients or not. Methods: This study was a case series involving six patients who underwent a Left Ventricular Assist Device (LVAD, Impella 2.5, Abiomed, Danvers, MA) implantation after suffering from AMI with a very low ejection fraction and acute heart failure. The clinical experience and outcomes of the patients are hereby discussed. Results: All PCI procedures were safely completed under LVAD support. The hemodynamic parameters of all patients improved clinically over the next 30 days and following 12 months after Impella insertion except in two patients, of which one patient (Case number 6) died 4 days post-Impella protected PCI procedure due to acute left ventricle heart failure with cardiogenic shock and pulmonary oedema; and another one died at 12 months after Impella protected PCI procedure (Case number 4) due to decompensated heart failure and infected pneumonia. Conclusion: Percutaneous hemodynamic support is favorable and feasible during high risk Percutaneous Coronary Intervention (PCI). A bigger study is needed to substantiate the claims of the current study.

Sign in / Sign up

Export Citation Format

Share Document